Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5078-5082

  Wierdl, M ^a   Morton, C L ^a   Weeks, J K ^a   Danks, M K ^a   Harris, L C ^a   Potter, P M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CARBOXYLESTERASE; IRINOTECAN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG EFFECT; DRUG EFFICACY; GENE TARGETING; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; TUMOR CELL;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOTRANSFORMATION; CAMPTOTHECIN; CARBOXYLESTERASE; CARBOXYLIC ESTER HYDROLASES; DNA, COMPLEMENTARY; DRUG SCREENING ASSAYS, ANTITUMOR; GENE THERAPY; GENETIC VECTORS; HUMANS; LIVER; RABBITS; RHABDOMYOSARCOMA; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035392963     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl10-(4-[1-piperidino]-I-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: Lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9- dimethylaminomethyl-10-hydroxycamptothecin
2. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
3. Efficacy of oral irinotecan against neuroblastoma xenografts
4. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts
5. Clinical pharmacokinetics of irinotecan
6. Direct translation of a protracted irinotecan schedule from a xenograft model to a Phase I trial in children
7. Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in Phase I/II trials
8. Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase
9. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11)
10. CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase
11. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials
12. Molecular aspects of carboxylesterase isoforms in comparison with other esterases
13. Activation of CPT-11 in mice: Identification and analysis of a highly effective plasma esterase
14. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy
15. Cellular localization domains of a rabbit and a human carboxylesterase: Influence on irinotecan (CPT-11) metabolism by the rabbit enzyme
16. Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda and COS7 cells for recombinant gene expression: Application to a rabbit liver carboxylesterase
17. Methods for construction of adenovirus vectors
18. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR
19. Analytical study of microsomes and isolated subcellular membranes from rat liver
20. Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase
21. Limited N-terminal sequence analysis
22. Rhabdomyosarcoma-specific expression of the Herpes simplex virus thymidine kinase gene confers sensitivity to ganciclovir
23. Construction of adenovirus for high level expression of small RNAs in mammalian cells: Application to a Bcl-2 ribozyme
24. Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11
25. In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors
26. A VDEPT approach to purging neuroblastoma cells from hematopoietic cells using adenovirus-encoding rabbit carboxylesterase and CPT-11